Attention-Deficit/Hyperactivity Disorder (ADHD) has seen an uptick in diagnoses over the past few decades. This increase has coincided with a greater awareness of the disorder, advancements in diagnostic methods, and the commercial availability of pharmaceutical treatments. Among these developments, the role of pharmaceutical solutions has been particularly pronounced, raising concerns about the potential negative consequences of tying ADHD too closely to medication solutions.
đ...
Continue reading...